Axsome Therapeutics Reports Third Quarter Results Exceeding Expectations
AXSM Axsome Therapeutics Inc
$140.97 +5.23%
View chart & analysis → - 1Axsome Therapeutics Inc reported a third-quarter loss per share of $0.25, exceeding the consensus estimate of -$0.69.
- 2Axsome Therapeutics Inc recorded a 63.8% beat against third-quarter expectations.
- 3AUVELITY net sales reached $207.6 million.
So what's the key point?
Axsome Therapeutics Inc released its earnings report, showing a smaller loss than experts had predicted. AUVELITY sales performed better than expected, surpassing $207.6 million.
Source Earnings Whispers · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.